Functions of all the plasma proteins
plasma proteins classification functions albumin globulin fibrinogen diagram

A pathophysiology diagram illustrating the mechanisms of hemostasis and the inhibitory effects of tick salivary proteins on platelet aggregation and plasma coagulation. The diagram is divided into the 'Blood Vessel Lumen' and the 'Extravascular Space.' On the left, 'Platelet Aggregation' is shown as a cluster of red spheres representing platelets cross-linked by fibrin strands; this process is inhibited by Lipocalins, Ixodegrins, and Serpins. On the right, the 'Plasma Coagulation' cascade is detailed, featuring both the Extrinsic pathway (initiated by Tissue Factor/TF due to trauma) and the Intrinsic pathway (activated via anionic surfaces). The diagram highlights key enzymatic conversions, such as Factor X to Xa/Va, Prothrombin to Thrombin, and Fibrinogen to Fibrin. Red annotation boxes identify specific tick protein families—including Kunitz-type inhibitors, BTSPs, and Serpins—that target and inhibit various coagulation factors like Thrombin, Factor Xa, and the XIIa/XIa complex. This visual resource effectively demonstrates the interference of exogenous biological agents with human blood clotting mechanisms.

This diagnostic diagram illustrates the results of a 100-nanosecond (ns) molecular dynamics (MD) simulation, showcasing the structural stability and temporal interaction between the compound acanthoic acid and three key human proteins: sex hormone-binding globulin (SHBG, Panel A), ADAM metallopeptidase domain 17 (ADAM17, Panel B), and Deoxyribonuclease I (DNase I, Panel C). The proteins are rendered as grey ribbon and tube models, representing their three-dimensional folds and binding pockets. Superimposed within these pockets are multicolored representations of acanthoic acid, highlighting its spatial trajectory at discrete time intervals: 0 ns (red), 20 ns (green), 40 ns (yellow), 60 ns (magenta), 80 ns (cyan), and 100 ns (orange). The tight clustering of these colored ligand orientations demonstrates a stable binding mode and consistent molecular positioning throughout the simulation. This visualization serves as a computational model in pharmaceutical research related to male fertility, specifically analyzing the potential for acanthoic acid to modulate these proteins' biological functions.

This bioinformatics flowchart details a virtual screening and in silico analysis pipeline for identifying antiviral peptide (AVP) candidates from rice bran proteins targeting SARS-CoV-2. The workflow begins with protein sequences (albumin, glutelin, globulin, prolamin) processed via the 'cleaver' R package for protease cut site prediction (pepsin, trypsin, chymotrypsin). This generates a dataset of 292 sequences, characterized by a pie chart showing peptide lengths (80% at 5-14 aa). The sequences undergo parallel screening using AVPpred, Meta-iAVP, and AMPfun. A Venn diagram illustrates the intersection of these results via Venny 2.1, leading to 71 AVP candidates that passed at least two predictors. COPid performs amino acid composition analysis. Candidates are further filtered through ENNAVIA for anti-coronavirus activity, resulting in the top 10 AVPs. Final characterization includes PEP-FOLD3 for secondary structure, GalaxyPepDock for Mpro interaction, and ToxinPred for toxicity. The pipeline concludes with visualization (UCSF Chimera), affinity analysis (PRODIGY+PIMA), and molecular dynamics simulation (LARMD).
| Fraction | Major Proteins |
|---|---|
| Albumin | Albumin |
| Alpha-1 globulins | alpha-1-antitrypsin, alpha-1-acid glycoprotein (orosomucoid), alpha-fetoprotein |
| Alpha-2 globulins | Haptoglobin, ceruloplasmin, alpha-2-macroglobulin, angiotensinogen |
| Beta globulins | Transferrin, beta-lipoprotein, hemopexin, C3/C4 complement |
| Gamma globulins | Immunoglobulins (IgG, IgA, IgM, IgD, IgE), CRP, SAA |
| Fibrinogen | Fibrinogen |
| Immunoglobulin | Key Functions |
|---|---|
| IgG (most abundant, 75%) | Secondary immune response; crosses placenta (passive neonatal immunity); opsonization; neutralization of toxins/viruses; complement activation (classical pathway) |
| IgA (serum + secretory) | Primary defense at mucosal surfaces (GI, respiratory, genitourinary tracts); prevents pathogen adherence to mucosa; found in breast milk, saliva, tears |
| IgM (pentamer) | First antibody in primary immune response; very efficient complement activator (classical pathway); agglutination of antigens; ABO blood group antibodies |
| IgD | B cell receptor co-receptor; role in B cell activation and differentiation |
| IgE | Mediates Type I hypersensitivity (allergy, anaphylaxis) by binding mast cells and basophils; defense against helminth parasites |
| Factor | Name | Function |
|---|---|---|
| I | Fibrinogen | Clot scaffold (see above) |
| II | Prothrombin | Precursor to thrombin (activates fibrinogen, V, VIII, XIII, platelets) |
| VII | Proconvertin | Initiates extrinsic pathway (with tissue factor) |
| VIII | Antihemophilic factor A | Cofactor in intrinsic pathway (tenase complex) |
| IX | Christmas factor | Intrinsic pathway serine protease |
| X | Stuart-Prower factor | Common pathway; activates prothrombin |
| XI | PTA | Intrinsic pathway |
| XII | Hageman factor | Contact activation; also activates complement and kinins |
| XIII | Fibrin-stabilizing factor | Cross-links fibrin clot |
| vWF | von Willebrand factor | Platelet adhesion; carries/stabilizes factor VIII |
| Protein | Function in Acute Phase |
|---|---|
| CRP (C-reactive protein) | Binds pathogens/damaged cells; activates complement; opsonization; anti-inflammatory (inhibits superoxide by neutrophils) |
| Serum amyloid A (SAA) | Chemotaxis and adhesion of phagocytes |
| Fibrinogen | Hemostasis; substrate for ESR |
| Haptoglobin | Antioxidant; binds free Hb |
| Ferritin | Iron sequestration (bacteriostatic) |
| Alpha-1-antitrypsin | Protease inhibition |
| Complement C3/C4 | Immune defense |
| Alpha-2-macroglobulin | Protease inhibition |